TRV GP IV, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001688325
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2024 · 3 positions · Total reported value $206.36M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q1 2024 13F filing, TRV GP IV, LLC disclosed 3 equity positions with a combined reported value of $206.36M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.
The largest disclosed positions as of Q1 2024 were TNGX ($152.46M), PLRX ($31.78M), FULC ($22.12M). By sector, the heaviest allocations are Health Care 100.0%.
Versus the prior quarter, TRV GP IV, LLC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Insider Transactions (Form 4)
Latest TRV GP IV, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
TRV GP IV is an SEC-registered 13F filer. As of Q2 2026 it reported 2 US equity positions with a combined value of $253.68M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 2 positions · $253.68M reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MAZE (MAZE THERAPEUTICS INC COM) at 52.6%
- Average position size: $126.84M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
FAQ
What did TRV GP IV, LLC buy in 2024-Q1?
In its 2024-Q1 13F filing, TRV GP IV, LLC reported 3 equity positions worth $206.36M in aggregate; its largest disclosed positions were TNGX ($152.46M), PLRX ($31.78M), FULC ($22.12M).
How large is TRV GP IV, LLC's portfolio?
TRV GP IV, LLC reported $206.36M of long equity holdings across 3 positions as of 2024-Q1. Top-10 holdings account for 100.0% of reported value.
What is TRV GP IV, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.